News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Viral Genetics Inc. (VRAL) Publishes March 2012 Monthly Letter to Shareholders


3/14/2012 6:59:09 AM

SAN MARINO, Calif.--(BUSINESS WIRE)--Viral Genetics (Pinksheets: VRAL) today published its March 2012 Letter to Shareholders. Providing updates on the company’s progress, the letter discusses the recent Pre-IND filing for its Lyme Disease drug candidate, notes other drugs in the pipeline that have developed out of the company’s Metabolic Disruption Technology Platform, and talks about progress in proving the efficacy of the yield enhancement in the company’s algal biofuels subsidiary, VG Energy.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES